B2B commercial sales diagnostic

The work starts with business questions. Is the company pursuing the right markets? Does the offer address a problem buyers prioritize? Is the pipeline composed of credible opportunities? Do stages represent customer progress? Can leaders distinguish an execution gap from a strategic gap?

We also examine whether teams share the same definitions. Marketing may consider a lead qualified while sales sees weak fit. SDRs may book meetings that executives do not accept. Forecast discussions may rely on intuition because CRM fields do not capture buying evidence.

The diagnostic turns these disagreements into explicit hypotheses. Some can be resolved through data. Others require interviews, samples, or controlled market tests.

The service is relevant when growth has slowed, pipeline feels unreliable, conversion has changed, or a team depends heavily on founders. It can also support a new market entry, a reorganization, a CRM project, or a decision between building and outsourcing sales capacity.

Companies often request a diagnostic after trying isolated actions such as hiring, changing tools, increasing lead volume, or rewriting scripts. These actions may be useful, but without a system view, it is difficult to know why they did or did not work.

A diagnostic can also confirm that part of the current model is sound. The goal is not to recommend change everywhere. It is to concentrate effort where it matters.

The scope is adapted to the business, but it may cover strategy, positioning, ideal customer profile, demand sources, prospecting, qualification, sales process, CRM, pipeline, forecasting, management, team structure, incentives, and handoffs.

We define the perimeter before the project begins. A focused assessment of prospecting requires different data and stakeholders from a company-wide commercial review. Clear boundaries protect depth and timing.

The proposal also identifies exclusions and dependencies. Legal, tax, accounting, and regulatory conclusions remain with qualified advisers. Product and financial decisions remain with company leadership.

The diagnostic evaluates whether the offer is described in language buyers recognize. Feature-heavy presentations may demonstrate capability without connecting it to a priority. Broad promises may sound attractive but fail to establish credibility.

We review website copy, outreach messages, sales presentations, proposals, and call samples when available. The objective is to identify consistency, clarity, evidence, and differences by audience.

We do not assess message quality only through opinion. Responses, objections, losses, and customer language provide evidence. Where evidence is limited, we recommend tests.

We map where opportunities originate and how each source performs. Inbound, outbound, partners, referrals, events, and account development may produce different fit and cycles.

For outbound, we review lists, data, segmentation, messages, channels, cadence, response handling, qualification, and handoff. Activity volume is considered, but not treated as the outcome.

The analysis also looks for concentration and dependency. A company that relies on one executive, partner, platform, or source may have a pipeline risk even when current results appear healthy.

Qualification should help the company decide where to invest, not simply fill required fields. We review criteria, questions, evidence, and the transition between SDRs and sales executives.

Discovery is evaluated for business context, problem, impact, priorities, stakeholders, alternatives, requirements, and decision process. A script can provide consistency, but the conversation must adapt.

We compare what teams say should happen with what records and samples show. Differences often reveal coaching, process, or incentive issues.

Forecast quality depends on evidence from the buying process. Dates and seller confidence alone are weak signals. We assess forecast categories, assumptions, stage probabilities, risks, and review practices.

Management meetings should help teams make decisions and develop opportunities. We observe whether routines focus only on totals or explore quality, next steps, blockers, and coaching.

We also examine how changes are governed. If definitions and targets change constantly, teams lose comparability. If nothing changes despite evidence, the process becomes rigid.

The diagnostic maps roles across marketing, intelligence, SDR, BDR, sales executives, leadership, operations, implementation, and customer success. Titles matter less than actual responsibilities.

We identify gaps, overlaps, unclear handoffs, and dependencies. A seller may appear unproductive while carrying research, administration, proposal production, and implementation coordination.

Capacity is considered alongside capability. A good process can still fail when the team cannot handle volume or when managers lack time for coaching.

Commercial quality becomes visible after signature. We review how objectives, scope, requirements, stakeholders, and commitments pass to implementation or customer teams.

Recurring onboarding problems may indicate qualification or expectation gaps. Churn, delays, expansion, and customer feedback can inform positioning and process, although attribution must be cautious.

The diagnostic recommends a feedback loop so that sales learns from delivery rather than optimizing only for contract signature.

The company names a sponsor, an operational contact, and the people who can explain strategy, sales, marketing, systems, and delivery. Access to CRM exports, reports, process documents, messages, proposals, and relevant samples is prepared according to security requirements.

Leadership should also describe previous initiatives and decisions that are not visible in the data. A failed experiment may contain important evidence. A current practice may exist because of a constraint the consultant would otherwise miss.

Participants do not need to agree before interviews. Different perspectives are useful when they are stated openly. Protagnst consolidates them into questions and checks them against available evidence.

Preliminary findings are reviewed with relevant stakeholders before the final roadmap. This step checks factual accuracy, missing context, and practical constraints. It does not require everyone to prefer the same recommendation.

Where data and interviews conflict, the report explains the difference. We may inspect additional samples or classify the point as uncertain. Strong language is reserved for findings with stronger evidence.

Validation improves implementation. Teams can see how the conclusion was reached, challenge assumptions, and understand what would change the recommendation.

Leadership can implement internally, engage Protagnst, work with other specialists, or postpone selected actions. The roadmap is structured so that ownership does not depend on continuing with the consultant.

If Protagnst supports implementation, scope and responsibilities are defined separately. Progress is reviewed against the baseline and the evidence expected from each change.

A B2B sales diagnostic creates value when it separates symptoms, identifies constraints, and gives leadership a sequence for action. It should reduce unfocused initiatives, not add another layer of theory.

Protagnst combines strategy, process, data, technology, and execution to examine the system as a whole. If your company needs to understand why pipeline, conversion, forecasting, or growth is not behaving as expected, we can build an evidence-based starting point.